The objective of the present study was to report the evolution of patients with a suggestive clinical scenario (1-5) and elevated IGF-1 (in two measurements and in the absence of another apparent cause), but GH suppression in the OGTT, in whom acromegaly was not initially excluded (2,8-12). Here, IGF1 is linked to acromegaly.